💨 Abstract

The Trump administration announced measures to end gender transition-related care for minors nationwide. The Department of Health and Human Services (HHS) will prohibit hospitals from providing puberty blockers, hormone therapy, and surgeries to minors as a condition for Medicare and Medicaid participation. The FDA will also issue warnings to manufacturers of chest binders for minors. Additionally, the HHS proposed excluding gender dysphoria from disability definitions under Section 504 of the Rehabilitation Act.

Courtesy: WTOP Staff